• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00570610
Device Problem Premature Activation (1484)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/20/2022
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The wallflex biliary stent has not been received for analysis.Upon receipt and completion of the device analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2022 that a wallflex biliary rx uncovered stent was to be implanted in the bile duct to treat a 3.5cm biliary obstruction during a stent placement procedure performed on (b)(6) 2022.Reportedly, the patient's anatomy was not tortuous and was dilated prior to stent placement.During the procedure, the wallflex biliary stent deployed prematurely and 2/3 of the stent was still inside the scope.The wallflex biliary stent was removed together within the scope and another wallflex biliary stent was implanted to complete the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on june 22, 2022 that a wallflex biliary rx uncovered stent was to be implanted in the bile duct to treat a 3.5cm biliary obstruction during a stent placement procedure performed on (b)(6) 2022.Reportedly, the patient's anatomy was not tortuous and was dilated prior to stent placement.During the procedure, the wallflex biliary stent deployed prematurely and 2/3 of the stent was still inside the scope.The wallflex biliary stent was removed together within the scope and another wallflex biliary stent was implanted to complete the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block h6: medical device problem code a150103 captures the reportable event of wallflex biliary stent deployed prematurely.Block h10: the wallflex biliary delivery system was received for analysis; the stent was not returned.Visual examination of the returned device found the outer clear sheath was accordioned near the tip.No other issues were noted to the delivery system.The damage observed to the delivery system was most likely due to procedural factors.It may be that the lesion characteristics, handling of the device, the technique used by the user, and/or normal procedural difficulties encountered during the procedure, limited the performance of the device, and contributed to outer sheath accordioned.However, the reported event of stent prematurely deployed could not be confirmed.This problem occurred during the procedure, and it is not possible to replicate in the laboratory of analysis.Therefore, a review and analysis of all available information indicated the most probable cause is no problem detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX BILIARY
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15018064
MDR Text Key304687793
Report Number3005099803-2022-03817
Device Sequence Number1
Product Code FGE
UDI-Device Identifier08714729759256
UDI-Public08714729759256
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K140630
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/14/2023
Device Model NumberM00570610
Device Catalogue Number7061
Device Lot Number0027661760
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/22/2022
Initial Date FDA Received07/14/2022
Supplement Dates Manufacturer Received10/05/2022
Supplement Dates FDA Received10/24/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/14/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age57 YR
Patient SexMale
Patient Weight60 KG
-
-